![Frontiers | Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report Frontiers | Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report](https://www.frontiersin.org/files/Articles/269340/fphar-08-00792-HTML/image_m/fphar-08-00792-g002.jpg)
Frontiers | Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-t001.jpg)
Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-g002.jpg)
Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-g004.jpg)
Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
![Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment](https://www.mdpi.com/cancers/cancers-13-05414/article_deploy/html/images/cancers-13-05414-g001-550.jpg)
Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-t003.jpg)
Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-g001.jpg)
Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
![Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial Frontiers | Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial](https://www.frontiersin.org/files/Articles/403277/fphar-09-00950-HTML-r1/image_m/fphar-09-00950-t002.jpg)